Efficacy of galcanezumab for migraine prevention in patients with a medical history of anxiety and/or depression: a post hoc analysis of the phase 3, randomized, double-blind, placebo-controlled REGAIN, and pooled EVOLVE-1 and EVOLVE-2 studies (vol 60, pg 2202, 2020)

被引：0
作者：
Smitherman, T. A.
机构：
来源：
HEADACHE | 2022年 / 62卷 / 01期
关键词：
D O I：
10.1111/head.14109
中图分类号：
R74 [神经病学与精神病学];
学科分类号：
摘要：
引用
收藏
页码：114 / 116
页数：3
相关论文
共 1 条
  • [1] Efficacy of Galcanezumab for Migraine Prevention in Patients With a Medical History of Anxiety and/or Depression: A Post Hoc Analysis of the Phase 3, Randomized, Double-Blind, Placebo-Controlled REGAIN, and Pooled EVOLVE-1 and EVOLVE-2 Studies
    Smitherman, Todd A.
    Tietjen, Gretchen E.
    Schuh, Kory
    Skljarevski, Vladimir
    Lipsius, Sarah
    D'Souza, Deborah N.
    Pearlman, Eric M.
    [J]. HEADACHE, 2020, 60 (10): : 2202 - 2219
1